Immunosuppression Regimens

Immunosuppression Regimens is a clinical protocol that systematically combines pharmacologic agents to selectively inhibit immune system activity in organ transplant recipients, thereby preventing allograft rejection while balancing the risks of infection and toxicity.

2.1K

Publications

113.8K

Citations

12.1K

Authors

2.1K

Institutions

Publications per year

2017–2026

300

Variants

Immunosuppressive Regimens

Authors

12.1K

  1. JJ
    John J. Fung

    University of Pittsburgh, United States

    48 publications · 5.1K citations

    33

    h-index

  2. TE
    Thomas E. Starzl

    University of Pittsburgh, United States

    35 publications · 3.7K citations

    27

    h-index

  3. RS
    Ron Shapiro

    University of Pittsburgh, United States

    21 publications · 2.2K citations

    20

    h-index

  4. BD
    Barry D. Kahan

    The University of Texas at Austin, United States

    19 publications · 1.1K citations

    18

    h-index

  5. AG
    Andreas G. Tzakis

    University of Miami, United States

    19 publications · 1.5K citations

    17

    h-index

1–5 of 12.1K

Venues

  1. Transplantation

    494 publications · 32.9K citations

    96

    h-index

  2. PubMed

    Repository · 269 publications · 10.2K citations

    52

    h-index

  3. American Journal of Transplantation

    97 publications · 9.8K citations

    51

    h-index

  4. Clinical Transplantation

    87 publications · 2.8K citations

    30

    h-index

  5. Liver Transplantation

    36 publications · 2.7K citations

    28

    h-index

1–5